PAA 2.70% 19.0¢ pharmaust limited

Ann: Board Changes, page-251

  1. 8,800 Posts.
    lightbulb Created with Sketch. 1684
    14 February 2024 first patient in extension study dosed as of 13 May no up date on progress after 3 months.
    10 March final approval for the remaing 2 patients to commence extension study given as of 13 May no up date on these 2 patients being dosed after one month
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.